Dania Khoulani

Dania Khoulani practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health.

Dania Khoulani's NPI, 1154610236, was assigned on March 29, 2011. Dania Khoulani graduated from Wayne State University School of Medicine in 2011. Dania Khoulani holds Michigan license 4301098717.

Dania Khoulani's primary practice is Corewell Health Beaumont Troy Hospital, at 44201 Dequindre Road, Troy, MI 48085 in Oakland County. The practice phone is (248) 964-8800.

Dania Khoulani's primary practice is Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health. Dania Khoulani is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dania Khoulani to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dania Khoulani practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dania Khoulani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dania Khoulani is licensed in Michigan.

CMS data shows 473 Medicare services from Dania Khoulani across 5 procedure codes in 2024, for 157 Medicare patients. Medicare paid $45,769 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dania Khoulani in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dania Khoulani's median patient age at 67, with 64% women.

In 2024, Dania Khoulani wrote 337 Medicare Part D claims for 55 patients. 86% of them were for generic drugs. CMS names the drug for 151 of them, across 9 drugs with 11 or more claims each, at $25,972 in total drug cost. In 2023, CMS named 155 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dania Khoulani for performance year 2024, reported as part of a group. Dania Khoulani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dania Khoulani from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $122.

Dania Khoulani graduated from Wayne State University School of Medicine in 2011.